Scopolamine (LSM-4015)HBr
Selleck Chemicals
SKU:S2508-50MG
Couldn't load pickup availability

Scopolamine (LSM-4015)HBr is an antagonist of AChR used in studies of Neurotransmission. It is especially relevant when investigators need a named chemical input and interpretable readouts connected to synaptic signaling, receptor activity, and neuronal excitability in neuroscience models.
By blocking AChR, Scopolamine (LSM-4015)HBr can be used to examine synaptic signaling, receptor activity, and neuronal excitability. This context is compatible with electrophysiology, neurotransmission, and receptor-response assays, as well as transcriptional, biochemical, or phenotypic comparisons linked to the annotated pathway state. In neuroscience models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.
Research Applications
- Target-focused assays involving AChR
- Pathway perturbation studies connected to Neurotransmission
- Receptor-blockade and ligand-competition studies
- Phenotypic profiling in neuroscience models
Overall, Scopolamine (LSM-4015)HBr is appropriate when a defined chemical perturbant is needed to connect AChR with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in neuroscience models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.
- Targets:
- AChR
- Target Class:
- Other
- Pathways:
- Neurotransmission
- Research Area:
- Neuroscience
- CAS No.:
- 114-49-8
- Molecular Weight:
- 384.26
- Formula:
- C₁₇H₂₁NO₄·HBr
- SMILES:
- CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4.Br
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.